Additional file 3: Table S2. of A randomized trial of the efficacy and safety of quilizumab in adults with inadequately controlled allergic asthma
收藏数据链接：
官方服务：
资源简介：
FEV1 at Week 36 (all patients and biomarker subgroups). (XLSX 48Â kb)
提供机构：
X. Liao; Weily Soong创建时间：
2016-12-15
